About Fischer Medical Ventures Limited
Data last updated: 14 July 2026
Fischer Medical Ventures Limited is a public limited company based in Pedagantyada, Andhra Pradesh, India. It specialises in chemical distribution and retail, a part of the broader chemicals and materials sector. Incorporated on 22 March 1993, the company has been in operation for over 33 years.
Registered with ROC Vijayawada under CIN L86900AP1993PLC118162. Listed on BSE: 524743.
Capital: an authorised share capital of ₹80 Cr and a paid-up capital of ₹65.45 Cr. Formerly known as Fischer Chemic Limited. It is led by directors including Jaya Ankur Singhania and Ravindran Govindan.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Pedagantyada, Andhra Pradesh.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹308.58 Cr. The net worth stands at ₹385.14 Cr. Total assets are valued at ₹671.01 Cr.
As per MCA filings, the company has open charges of ₹40 Cr and satisfied charges of ₹20.63 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fischerchemic.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressSurvey No. 480/2 Ap Medtech Zone Nadupura Village, Pedagantyadu Mandal Visakhapatnam, Pedagantyada, Andhra Pradesh, India – 530031
-
IndustryChemicals and Materials, Chemical Distribution & Retail
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L86900AP1993PLC118162, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L86900AP1993PLC118162 | Current |
| L24231TN1993PLC024661 | Previous |
| L86900MH1993PLC288371 | Previous |
| L24231MH1993PLC288371 | Previous |
Business Activity of Fischer Medical Ventures Limited
Fischer Medical Ventures Limited operates primarily in the trade sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Trade | Locked | Wholesale Trading | Locked |
Detailed business activity records for Fischer Medical Ventures Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Fischer Medical Ventures Limited
Fischer Medical Ventures Limited is audited by Bilimoria Mehta & Co (ICAI peer reviewed, certificate valid till 2027-06-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Bilimoria Mehta & Co (ICAI peer reviewed, certificate valid till 2027-06-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Fischer Medical Ventures Limited
Fischer Medical Ventures Limited is currently managed by 8 directors, with 28 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Jaya Ankur Singhania
Also directs:
Avabodha Bharat Legal Advisory & Training Llp, J S Singhania And Co. Llp, Sudarshan Pharma Industries Limited and 5 more
|
Director | 26 Mar 2025 | 1 Years 3 Months | Current |
| Ravindran Govindan | Managing Director | 04 May 2024 | 2 Years 2 Months | Current |
| Svetlana Rao Raviwada | Whole-Time Director | 04 May 2024 | 2 Years 2 Months | Current |
| Sanjay Jayantilal Jain | Director | 12 Oct 2021 | 4 Years 9 Months | Current |
|
Khairy Jamaluddin Abu Bakar
Also directs:
Fischer Medical Ventures Limited
|
Director | 04 May 2024 | 2 Years 2 Months | Current |
|
Roberto Mamangon Pagdanganan
Also directs:
Fischer Medical Ventures Limited
|
Director | 05 Jul 2024 | 2 Years 0 Months | Current |
Financials of Fischer Medical Ventures Limited FY 2026 filings available
Fischer Medical Ventures Limited reported revenue of ₹308.58 Cr for FY 2026.
| Metrics | FY 2026 |
|---|---|
| Revenue from Operations | ₹308.58 Cr |
| Other Income | ₹12.31 Cr |
| Total Income | ₹320.89 Cr |
| Cost of Materials Consumed | ₹62.24 Cr |
| Purchases of Stock-in-Trade | ₹83.49 Cr |
| Changes in Inventories | -₹3.16 Cr |
| Employee Benefit Expense | ₹15.09 Cr |
| Finance Costs | ₹5.83 Cr |
| Depreciation & Amortisation | ₹2.98 Cr |
| Other Expenses | ₹107.82 Cr |
| Total Expenses | ₹274.31 Cr |
| Profit Before Exceptional Items & Tax | ₹46.58 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | ₹46.58 Cr |
| Total Tax Expense | ₹15.34 Cr |
| Net Profit | ₹31.02 Cr |
| Other Comprehensive Income | ₹5.43 Lakh |
| Total Comprehensive Income | ₹31.07 Cr |
| EBITDA (computed) | ₹55.4 Cr |
| Basic EPS | ₹0.48 |
| Diluted EPS | ₹0.45 |
| Metrics | FY 2026 |
|---|---|
| Total Assets | ₹671.01 Cr |
| Non-current Assets | ₹253.42 Cr |
| Current Assets | ₹417.59 Cr |
| Property, Plant & Equipment | ₹12.48 Cr |
| Inventories | ₹12.66 Cr |
| Trade Receivables | ₹288.8 Cr |
| Cash & Equivalents | ₹11.89 Cr |
| Equity (Net Worth) | ₹385.14 Cr |
| Equity Share Capital | ₹65.45 Cr |
| Borrowings (Non-current) | ₹26.09 Lakh |
| Borrowings (Current) | ₹72.1 Cr |
| Total Debt (computed) | ₹72.36 Cr |
| Current Liabilities | ₹258.03 Cr |
| Total Liabilities | ₹285.87 Cr |
| Metrics | FY 2026 |
|---|---|
| Operating Cash Flow | -₹101.27 Cr |
| Investing Cash Flow | -₹5.22 Cr |
| Financing Cash Flow | ₹14.11 Cr |
| Capital Expenditure | ₹1.31 Cr |
| Free Cash Flow (computed) | -₹102.58 Cr |
| Dividends Paid | ₹27.44 Lakh |
| Net Change in Cash | -₹92.37 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|---|
| Revenue from Operations | ₹97.73 Cr | ₹101.1 Cr | ₹86.31 Cr | ₹23.44 Cr |
| Other Income | ₹1.28 Cr | ₹1.09 Cr | ₹2.48 Cr | ₹7.47 Cr |
| Total Income | ₹99.01 Cr | ₹102.18 Cr | ₹88.79 Cr | ₹30.91 Cr |
| Cost of Materials Consumed | ₹62.09 Cr | ₹0 | ₹14.89 Lakh | ₹7.58 Cr |
| Purchases of Stock-in-Trade | ₹6.9 Cr | ₹57.81 Cr | ₹11.2 Cr | ₹0 |
| Changes in Inventories | -₹53.55 Lakh | -₹8.92 Cr | ₹1.34 Cr | ₹4.96 Cr |
| Employee Benefit Expense | ₹4.02 Cr | ₹4.17 Cr | ₹3.75 Cr | ₹3.16 Cr |
| Finance Costs | ₹3.61 Cr | ₹63.71 Lakh | ₹91.87 Lakh | ₹66.99 Lakh |
| Depreciation & Amortisation | ₹92.57 Lakh | ₹77.01 Lakh | ₹51.37 Lakh | ₹76.97 Lakh |
| Other Expenses | ₹24.24 Cr | ₹26.47 Cr | ₹53.62 Cr | ₹3.48 Cr |
| Total Expenses | ₹101.26 Cr | ₹80.94 Cr | ₹71.48 Cr | ₹20.62 Cr |
| Profit Before Exceptional Items & Tax | -₹2.25 Cr | ₹21.25 Cr | ₹17.3 Cr | ₹10.29 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹2.25 Cr | ₹21.25 Cr | ₹17.3 Cr | ₹10.29 Cr |
| Total Tax Expense | ₹4.86 Cr | ₹1.95 Cr | ₹3.37 Cr | ₹5.17 Cr |
| Net Profit | -₹7.12 Cr | ₹19.23 Cr | ₹13.9 Cr | ₹5.01 Cr |
| attributable to Owners | - | ₹7.38 Lakh | -₹78,000 | - |
| attributable to NCI | - | -₹13.12 Lakh | -₹65,000 | - |
| Other Comprehensive Income | ₹0 | ₹0 | ₹6.32 Lakh | ₹0 |
| Total Comprehensive Income | -₹7.12 Cr | ₹19.23 Cr | ₹13.96 Cr | ₹5.01 Cr |
| EBITDA (computed) | ₹2.28 Cr | ₹22.65 Cr | ₹18.74 Cr | ₹11.73 Cr |
| Basic EPS | ₹-0.11 | ₹0.30 | ₹2.15 | ₹0.77 |
| Diluted EPS | ₹0.10 | ₹0.29 | ₹2.11 | ₹0.76 |
| Metrics | FY 2026 |
|---|---|
| Revenue from Operations | ₹17.39 Cr |
| Other Income | ₹3.49 Cr |
| Total Income | ₹20.89 Cr |
| Cost of Materials Consumed | ₹0 |
| Purchases of Stock-in-Trade | ₹11.96 Cr |
| Changes in Inventories | -₹35.45 Lakh |
| Employee Benefit Expense | ₹2.02 Cr |
| Finance Costs | ₹4.65 Cr |
| Depreciation & Amortisation | ₹67.86 Lakh |
| Other Expenses | ₹12.44 Cr |
| Total Expenses | ₹31.39 Cr |
| Profit Before Exceptional Items & Tax | -₹10.51 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | -₹10.51 Cr |
| Total Tax Expense | -₹8.29 Lakh |
| Net Profit | -₹10.42 Cr |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | -₹10.42 Cr |
| EBITDA (computed) | -₹5.17 Cr |
| Basic EPS | ₹-0.16 |
| Diluted EPS | ₹-0.15 |
| Metrics | FY 2026 |
|---|---|
| Total Assets | ₹388.65 Cr |
| Non-current Assets | ₹359.07 Cr |
| Current Assets | ₹29.58 Cr |
| Property, Plant & Equipment | ₹2.91 Lakh |
| Inventories | ₹41.95 Lakh |
| Trade Receivables | ₹20.71 Cr |
| Cash & Equivalents | ₹1.14 Cr |
| Equity (Net Worth) | ₹338.13 Cr |
| Equity Share Capital | ₹65.45 Cr |
| Borrowings (Non-current) | ₹12.97 Cr |
| Borrowings (Current) | ₹0 |
| Total Debt (computed) | ₹12.97 Cr |
| Current Liabilities | ₹11.85 Cr |
| Total Liabilities | ₹50.52 Cr |
| Metrics | FY 2026 |
|---|---|
| Operating Cash Flow | -₹2.91 Cr |
| Investing Cash Flow | -₹13.27 Cr |
| Financing Cash Flow | ₹17.02 Cr |
| Capital Expenditure | ₹2.93 Lakh |
| Free Cash Flow (computed) | -₹2.94 Cr |
| Dividends Paid | ₹27.44 Lakh |
| Net Change in Cash | ₹85.11 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|---|
| Revenue from Operations | ₹4.11 Cr | ₹1.32 Cr | ₹7.43 Cr | ₹4.54 Cr |
| Other Income | ₹43.4 Lakh | ₹85.67 Lakh | ₹1.43 Cr | ₹80.4 Lakh |
| Total Income | ₹4.54 Cr | ₹2.17 Cr | ₹8.86 Cr | ₹5.35 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹2.77 Cr | ₹1.37 Cr | ₹4.63 Cr | ₹3.19 Cr |
| Changes in Inventories | ₹4.58 Lakh | -₹40.03 Lakh | ₹0 | ₹0 |
| Employee Benefit Expense | ₹52.39 Lakh | ₹61.81 Lakh | ₹45.46 Lakh | ₹41.75 Lakh |
| Finance Costs | ₹1.27 Cr | ₹95.89 Lakh | ₹1.12 Cr | ₹1.31 Cr |
| Depreciation & Amortisation | ₹43.39 Lakh | ₹8.16 Lakh | ₹8.16 Lakh | ₹8.16 Lakh |
| Other Expenses | ₹9.67 Cr | ₹1.05 Cr | ₹1.19 Cr | ₹56.8 Lakh |
| Total Expenses | ₹14.71 Cr | ₹3.67 Cr | ₹7.48 Cr | ₹5.56 Cr |
| Profit Before Exceptional Items & Tax | -₹10.17 Cr | -₹1.5 Cr | ₹1.38 Cr | -₹21.55 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹10.17 Cr | -₹1.5 Cr | ₹1.38 Cr | -₹21.55 Lakh |
| Total Tax Expense | -₹1.19 Cr | ₹16.77 Lakh | ₹54.05 Lakh | ₹39.38 Lakh |
| Net Profit | -₹8.98 Cr | -₹1.67 Cr | ₹83.77 Lakh | -₹60.93 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹8.98 Cr | -₹1.67 Cr | ₹83.77 Lakh | -₹60.93 Lakh |
| EBITDA (computed) | -₹8.47 Cr | -₹46.11 Lakh | ₹2.58 Cr | ₹1.17 Cr |
| Basic EPS | ₹-0.14 | ₹-0.03 | ₹0.13 | ₹-0.09 |
| Diluted EPS | ₹-0.13 | ₹-0.03 | ₹0.13 | ₹-0.09 |
Shareholding Pattern of Fischer Medical Ventures Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 62.15%, foreign institutional investors hold 4.97%, domestic institutional investors hold 1.38%, retail and other public shareholders hold 31.50% of Fischer Medical Ventures Limited. The company had 23,269 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jul 2025 | Jun 2025 | |
|---|---|---|---|---|---|
| Promoters | 62.15% | 61.80% | 61.80% | 61.80% | 61.80% |
| Public | 37.85% | 38.20% | 38.20% | 38.20% | 38.20% |
Board & Governance of Fischer Medical Ventures Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Fischer Medical Ventures Limited has 8 directors - 6 independent and 2 executive. The board is chaired by RAVINDRAN GOVINDAN.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| RAVINDRAN GOVINDAN | Executive Director · MD · Chairperson | 2024-05-04 | 1 |
| SVETLANA RAO RAVIWADA | Executive Director | 2024-05-04 | 1 |
| KHAIRY JAMALUDDIN ABU BAKAR | Non-Executive - Independent Director | 2024-05-04 | 1 |
| SANJAY JAYANTILAL JAIN | Non-Executive - Independent Director | 2021-10-12 | 1 |
| ROBERTO M PADGDANGANAN | Non-Executive - Independent Director | 2024-07-05 | 1 |
| JAYA ANKUR SINGHANIA | Non-Executive - Independent Director | 2025-03-26 | 4 |
| CHAN SING EN | Non-Executive - Independent Director | 2025-10-28 | 1 |
| SYED JALALUDIN | Non-Executive - Independent Director | 2025-11-30 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | KHAIRY JAMALUDDIN ABU BAKAR (Chairperson), SANJAY JAYANTILAL JAIN, RAVINDRAN GOVINDAN, JAYA ANKUR SINGHANIA, ROBERTO M PADGDANGANAN, CHAN SING EN, SYED JALALUDIN |
| Nomination and remuneration committee | KHAIRY JAMALUDDIN ABU BAKAR (Chairperson), ROBERTO M PADGDANGANAN, JAYA ANKUR SINGHANIA, RAVINDRAN GOVINDAN, SYED JALALUDIN |
| Stakeholders Relationship Committee | JAYA ANKUR SINGHANIA (Chairperson), SVETLANA RAO RAVIWADA, RAVINDRAN GOVINDAN |
| Risk Management Committee | SVETLANA RAO RAVIWADA (Chairperson), RAVINDRAN GOVINDAN, KHAIRY JAMALUDDIN ABU BAKAR, JAYA ANKUR SINGHANIA, CHAN SING EN |
| Corporate Social Responsibility Committee | SVETLANA RAO RAVIWADA (Chairperson), ROBERTO M PADGDANGANAN, JAYA ANKUR SINGHANIA, RAVINDRAN GOVINDAN, CHAN SING EN |
Charges & Borrowings of Fischer Medical Ventures Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2026 | Others | ₹15 Cr | Open |
| 28 Mar 2025 | Others | ₹25 Cr | Open |
| 30 May 2005 | Sundaram Finance Limited | ₹20.63 Lakh | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has a workforce of 0 employees as of Sep 26, 2025.
Employee and EPFO history for Fischer Medical Ventures Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Fischer Medical Ventures Limited
GST registrations and filing compliance for Fischer Medical Ventures Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Fischer Medical Ventures Limited
Credit ratings, litigation, and regulatory alerts for Fischer Medical Ventures Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Fischer Medical Ventures Limited
MSME payment history for Fischer Medical Ventures Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fischer Medical Ventures Limited
Corporate group structure for Fischer Medical Ventures Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fischer Medical Ventures Limited
MCA filings and documents for Fischer Medical Ventures Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Fischer Medical Ventures Limited
Frequently Asked Questions about Fischer Medical Ventures Limited
Fischer Medical Ventures Limited is an active public limited company in the chemicals and materials sector based in Pedagantyada, Andhra Pradesh, India. It was incorporated on 22 March 1993 (33+ years old) and is registered under CIN L86900AP1993PLC118162. Listed on BSE: 524743.
Fischer Medical Ventures Limited reported revenue of ₹308.58 Cr for FY 2026 based on consolidated NSE filings.
The current directors of Fischer Medical Ventures Limited are:
- Jaya Ankur Singhania - Director
- Ravindran Govindan - Managing Director
- Svetlana Rao Raviwada - Whole-Time Director
- Sanjay Jayantilal Jain - Director
- Khairy Jamaluddin Abu Bakar - Director
- Roberto Mamangon Pagdanganan - Director
- Chan Sing En - Director
- Syed Jalaludin - Director
The primary industry of Fischer Medical Ventures Limited is chemicals and materials. The company specifically operates in chemical distribution and retail. The company is currently active in this sector.
Yes. Fischer Medical Ventures Limited is listed on BSE with code 524743.
Fischer Medical Ventures Limited can be reached at the registered office: Survey No. 4802 Ap Medtech Zone Nadupura Village, Pedagantyadu Mandal Visakhapatnam, Pedagantyada, Andhra Pradesh, India – 530031, or through the website fischerchemic.in.